BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28560815)

  • 1. Covariate-adjusted borrowing of historical control data in randomized clinical trials.
    Han B; Zhan J; John Zhong Z; Liu D; Lindborg S
    Pharm Stat; 2017 Jul; 16(4):296-308. PubMed ID: 28560815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.
    Smith CL; Thomas Z; Enas N; Thorn K; Lahn M; Benhadji K; Cleverly A
    Pharm Stat; 2020 May; 19(3):276-290. PubMed ID: 31903699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and analysis of a clinical trial using previous trials as historical control.
    Schoenfeld DA; Finkelstein DM; Macklin E; Zach N; Ennist DL; Taylor AA; Atassi N;
    Clin Trials; 2019 Oct; 16(5):531-538. PubMed ID: 31256630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
    Harun N; Liu C; Kim MO
    Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian Method of Borrowing Study-Level Historical Longitudinal Control Data for Mixed-Effects Models with Repeated Measures.
    Li H; Jin M; Chung YC; Zhong S; Wang L
    Ther Innov Regul Sci; 2023 Jan; 57(1):142-151. PubMed ID: 36315398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
    Liu GF
    Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
    Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
    Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inclusion of historical control data may reduce the power of a confirmatory study.
    Cuffe RL
    Stat Med; 2011 May; 30(12):1329-38. PubMed ID: 21432893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian adaptive design for covariate-adaptive historical control information borrowing.
    Jin H; Kim MO; Scheffler A; Jiang F
    Stat Med; 2023 Dec; 42(29):5338-5352. PubMed ID: 37750361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
    Sawamoto R; Oba K; Matsuyama Y
    Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practical Bayesian adaptive design incorporating data from historical controls.
    Psioda MA; Soukup M; Ibrahim JG
    Stat Med; 2018 Nov; 37(27):4054-4070. PubMed ID: 30033617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments.
    Kaplan D; Chen J; Yavuz S; Lyu W
    Psychometrika; 2023 Mar; 88(1):1-30. PubMed ID: 35687222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
    Quan H; Zhang B; Lan Y; Luo X; Chen X
    Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion?
    Galwey NW
    Stat Med; 2017 Mar; 36(6):899-916. PubMed ID: 27925274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Super-covariates": Using predicted control group outcome as a covariate in randomized clinical trials.
    Holzhauer B; Adewuyi ET
    Pharm Stat; 2023; 22(6):1062-1075. PubMed ID: 37553959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials.
    Ohigashi T; Maruo K; Sozu T; Gosho M
    Stat Methods Med Res; 2022 Jul; 31(7):1392-1404. PubMed ID: 35379046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting.
    Harari O; Soltanifar M; Verhoek A; Heeg B
    Pharm Stat; 2023; 22(5):903-920. PubMed ID: 37321565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of historical control data for assessing treatment effects in clinical trials.
    Viele K; Berry S; Neuenschwander B; Amzal B; Chen F; Enas N; Hobbs B; Ibrahim JG; Kinnersley N; Lindborg S; Micallef S; Roychoudhury S; Thompson L
    Pharm Stat; 2014; 13(1):41-54. PubMed ID: 23913901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.